Literature DB >> 22227585

HIV treatment as prevention and HPTN 052.

Myron S Cohen1, Marybeth McCauley, Theresa R Gamble.   

Abstract

PURPOSE OF REVIEW: This review summarizes the development and implementation of a large clinical trial, HIV Prevention Trials Network (HPTN) 052, whose initial results were recently presented and published. RECENT
FINDINGS: A randomized, clinical trial demonstrated that antiretroviral therapy reduces the sexual transmission of HIV in HIV-serodiscordant couples by more than 96%. The logistical challenges in preparing for and conducting such a trial were considerable.
SUMMARY: HPTN 052 required many years of preparation, considerable collaboration between National Institute of Health and six pharmaceutical companies, and careful ongoing consideration of a large number of ethical issues. HPTN 052 revealed the magnitude of benefit when using antiretroviral therapy to prevent the transmission of HIV, and served as proof of a concept. The results have proven central to the development of new global HIV-prevention efforts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22227585      PMCID: PMC3486734          DOI: 10.1097/COH.0b013e32834f5cf2

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  60 in total

Review 1.  Antiretroviral drug concentrations in semen of HIV-1 infected men.

Authors:  S Taylor; A S Pereira
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

2.  Modelling the effect of combination antiretroviral treatments on HIV incidence.

Authors:  M G Law; G Prestage; A Grulich; P Van de Ven; S Kippax
Journal:  AIDS       Date:  2001-07-06       Impact factor: 4.177

Review 3.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Authors:  J X Velasco-Hernandez; H B Gershengorn; S M Blower
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

4.  Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.

Authors:  Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

5.  Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen.

Authors:  B L Gilliam; J R Dyer; S A Fiscus; C Marcus; S Zhou; L Wathen; W W Freimuth; M S Cohen; J J Eron
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-05-01

6.  Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.

Authors:  Cynthia Firnhaber; Laura Smeaton; Nasinuku Saukila; Timothy Flanigan; Raman Gangakhedkar; Johnstone Kumwenda; Alberto La Rosa; Nagalingeswaran Kumarasamy; Victor De Gruttola; James Gita Hakim; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2010-10-18       Impact factor: 3.623

7.  Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates.

Authors:  S C Kalichman; M Cage; T Barnett; P Tharnish; D Rompa; J Austin; W Luke; J O'Mowrey; R F Schinazi
Journal:  AIDS Res Hum Retroviruses       Date:  2001-12-10       Impact factor: 2.205

8.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

9.  Highly active antiretroviral treatment for the prevention of HIV transmission.

Authors:  Reuben Granich; Siobhan Crowley; Marco Vitoria; Ying-Ru Lo; Yves Souteyrand; Christopher Dye; Charlie Gilks; Teguest Guerma; Kevin M De Cock; Brian Williams
Journal:  J Int AIDS Soc       Date:  2010-01-12       Impact factor: 5.396

10.  When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Authors:  Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

View more
  111 in total

1.  Integrating HIV Prevention and Relationship Education for Young Same-Sex Male Couples: A Pilot Trial of the 2GETHER Intervention.

Authors:  Michael E Newcomb; Kathryn R Macapagal; Brian A Feinstein; Emily Bettin; Gregory Swann; Sarah W Whitton
Journal:  AIDS Behav       Date:  2017-08

2.  Seeing Is Believing? Unique Capabilities of Internet-Only Studies as a Tool for Implementation Research on HIV Prevention for Men Who Have Sex With Men: A Review of Studies and Methodological Considerations.

Authors:  Christian Grov; Drew Westmoreland; H Jonathon Rendina; Denis Nash
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12       Impact factor: 3.731

3.  Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy?

Authors:  John A Sauceda; John S Wiebe; Jane M Simoni
Journal:  J Health Psychol       Date:  2014-08-25

4.  Curriculum development to increase minority research literacy for HIV prevention research: a CBPR approach.

Authors:  Malika Roman Isler; Andre L Brown; Natalie Eley; Allison Mathews; Kendra Batten; Randy Rogers; Noah Powell; Caressa White; Rosalee Underwood; Kathleen M MacQueen
Journal:  Prog Community Health Partnersh       Date:  2014

5.  Bridging Research, Practice, and Policy: The "Evidence Academy" Conference Model.

Authors:  Catherine L Rohweder; Jane L Laping; Sandra J Diehl; Alexis A Moore; Malika Roman Isler; Jennifer Elissa Scott; Zoe Kaori Enga; Molly C Black; Gaurav Dave; Giselle Corbie-Smith; Cathy L Melvin
Journal:  J Public Health Manag Pract       Date:  2016 Mar-Apr

6.  Validation of the HIV Risk Assessment of Sexual Partnerships (H-RASP): Comparison to a 2-Month Prospective Diary Study.

Authors:  Gregory Swann; Michael E Newcomb; Brian Mustanski
Journal:  Arch Sex Behav       Date:  2017-07-21

Review 7.  Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions.

Authors:  Tina Jiwatram-Negrón; Nabila El-Bassel
Journal:  AIDS Behav       Date:  2014-10

8.  Case Management: Steadfast Resource for Addressing Linkage to Care and Prevention with Hospitalized HIV-Infected Crack Users.

Authors:  Sonjia Kenya; Natasha Chida; Gabriel Cardenas; Margaret Pereyra; Carlos Del Rio; Allan Rodriguez; Lisa Metsch
Journal:  J HIV AIDS Soc Serv       Date:  2014

Review 9.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

10.  Social-Environmental Resilience, PrEP Uptake, and Viral Suppression among Young Black Men Who Have Sex with Men and Young Black Transgender Women: the Neighborhoods and Networks (N2) Study in Chicago.

Authors:  Yen-Tyng Chen; Dustin T Duncan; Rodal Issema; William C Goedel; Denton Callander; Benjamin Bernard-Herman; Hillary Hanson; Rebecca Eavou; John Schneider; Anna Hotton
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.